Saudat Fadeyi, PhD, MBA

Head of Business Development and Strategy at Samyang Biopharm USA

Speaker

Saudat Fadeyi is a science-driven business leader with over 17 years of experience in the pharmaceutical and biotechnology industry. Her expertise spans global drug development, corporate strategy, business development, and licensing, with a focus on bringing innovative therapies and enabling technology from discovery to market.

As Head of Business Development & Strategy at Samyang Biopharm USA, Saudat leads efforts to advance a portfolio of novel non-viral nanoparticle gene delivery modalities through driving strategic partnerships and licensing agreements with companies focused on RNA therapeutics. Prior to this, she led Business Development & Partnering at Ovid Therapeutics, where she executed transformative deal transactions across multiple stages of development, targeting rare neurological diseases and high unmet medical needs.

Saudat began her career at Schering-Plough and has held leadership roles at Pfizer and Sage Therapeutics, contributing to diverse therapeutic areas, including oncology, metabolic disorders, infectious diseases, inflammation, and neurology. With a strong foundation in translational research and clinical development, she has played a key role in advancing multiple early- to late-stage drug programs, including several marketed products.

Saudat holds a PhD in Cancer Biology and an MBA in Pharmaceutical Management. She completed her postdoctoral training at the National Institutes of Health (NIH), specializing in immuno-oncology and vaccine development.